Physician profile

Jerry A Nick

Pulmonary Disease · Denver, CO

NPI 1417047192

$28,931.47

in general payments reported to CMS, 2019-2025

16 companies · $161 in 2025

The $161 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$381.94
Education$17.38

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Vertex Pharmaceuticals Incorporated $10,991.22 2019-2024 Trikafta
Gilead Sciences, INC. $10,312.47 2019-2021
Lupin INC. $2,655.00 2021
Alcresta Therapeutics, INC. $2,500.00 2021
Chiesi USA, INC. $1,048.53 2020-2022
Abbvie INC. $323.83 2019-2025
Insmed, INC. $313.84 2019-2025
Paratek Pharmaceuticals, INC. $179.77 2020-2025 Nuzyra
Allergan, INC. $149.66 2019-2020
Nestle Healthcare Nutrition INC. $135.81 2021-2023
Advanced Respiratory, INC $104.08 2019-2020
Mylan Specialty L.P. $88.08 2019-2023 Tobi Podhaler
Vivus LLC $48.11 2021-2023 Pancreaze
Pari Respiratory Equipment, INC. $42.24 2020
Digestive Care, INC. $23.44 2023 Pertzye
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Aimmune Therapeutics, INC. $15.39 2025 Zenpep

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jerry A Nick

$28,931.47

in general payments reported 2019-2025

Years
2019-2025
Top company
Vertex Pharmaceuticals Incorporated
Context
The $161 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/18885/jerry-a-nick

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.